Article published in Journal of Controlled Release by Van IJzendoorn group
18 January 2024
 |
Nanoparticles targeting the intestinal Fc receptor enhance intestinal cellular trafficking of semaglutide.
Pinto S, Hosseini M, Buckley S, Yin W, Garousi J, Gräslund T, van Ijzendoorn S, Santos HA, Sarmento B. J. Contr. Rel., Volume 366, February 2024, Pages 621-636. doi: 10.1016/j.jconrel.2024.01.015. |
